French inflammatory diseases specialist Abivax yesterday announced the closing of its previously announced underwritten ...
Codis has agreed to acquire Catalent Pharma Solutions’ Nottingham, UK, facility, expanding its contract development and manufacturing organization (CDMO) capabilities in oral solid dose development ...
France-based life sciences venture capital firm Sofinnova today announced that its portfolio company Myricx Bio has reached ...
AlzeCure Pharma has signed an out-licensing and collaboration agreement with Denmark’s privately held QuantumCell, granting ...
Danish biotech company Muna Therapeutics has named Michel Detheux as chief executive as it prepares to move its lead ...
India’s Orchid Pharma is in advanced negotiations to out-license its breakthrough antibiotic enmetazobactam in the USA, a move that could mark the company’s commercial entry into the world’s largest ...
Danish drugmaker Novo Nordisk has won conditional UK marketing authorization for Wegovy (semaglutide) in adults with metabolic dysfunction-associated steatohepatitis (MASH) and moderate-to-advanced ...
US drugmaker United Therapeutics yesterday revealed that it has acquired Thymmune Therapeutics, a privately held, pre-clinical stage biotechnology company.
US oncology biotech Revolution Medicines has reported early Phase I/II data for zoldonrasib-based combinations in RAS G12D-mutant metastatic pancreatic ductal adenocarcinoma (PDAC), supporting two ...
Scribe Therapeutics, a Phase I biotech developing CRISPR therapies for cardiovascular diseases, filed on Thursday with the Securities & Exchange Commission (SEC) to raise up to $75 million in an ...
Russian pharmaceutical companies and global drugmakers operating in the local market have called on the national government to speed the process of entering new drugs in public procurements after ...
As real-world evidence (RWE) increasingly shapes competition in the relapsing multiple sclerosis (RMS) market, TG Therapeutics is leaning on patient-reported outcomes to carve out space for Briumvi ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results